Context Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4 | |||
EBITDA | -8,823 | -5,525 | -4,307 | -18,699 |
EBIT | -8,827 | -5,529 | -4,309 | -18,701 |
Net Income | -8,827 | -4,577 | -3,343 | -17,460 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | 5,028 | -5,062 | -4,907 | -16,690 |
Cash | 83,517 | 89,352 | 94,429 | 84,801 |
Basic Shares | 95,186 | 95,187 | 58,416 | 80,481 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -12 | -9 | ||
EBITDA | -26,672 | -25,061 | -14,827 | -10,526 |
EBIT | -26,724 | -25,073 | -14,836 | -7,438 |
Net Income | -26,725 | -23,964 | -14,836 | -10,457 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -29,314 | -21,047 | -14,086 | -9,049 |
Cash | 94,429 | 14,449 | 35,497 | 49,635 |
Basic Shares | 58,416 | 15,966 | 15,966 | 2,834 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.09 |
2025-03-31 | -$0.05 |
2024-12-31 | -$0.03 |
